Financial Gravity Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Financial Gravity Asset Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-50	Closed	–	–	1713
2019 Q2	$0	Hold	50	–	–	﹤0.01%	1847
2019 Q1	$0	Buy	+50	New	+$237	﹤0.01%	1643
2018 Q3	$0	Sell	52 -3	-5%	-$24	﹤0.01%	1712
2018 Q2	$0	Sell	55 -2	-4%	-$14	﹤0.01%	1708
2018 Q1	$0	Buy	+57	New	+$471	﹤0.01%	1558

Financial Gravity Asset Management's INSY Position: Q3 2019 in Review

Financial Gravity Asset Management sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 50 shares.

Financial Gravity Asset Management first reported a position in INSY in Q1 2018 and held it in 5 quarters. The position peaked at $0 in Q2 2019. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

Financial Gravity Asset Management reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Financial Gravity Asset Management sold 50 Insys Therapeutics, Inc. shares in Q3 2019.
Financial Gravity Asset Management first reported a position in Insys Therapeutics, Inc. in Q1 2018 and held it in 5 quarters.
Financial Gravity Asset Management's Insys Therapeutics, Inc. position peaked at $0 in Q2 2019.
4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Financial Gravity Asset Management's 13F filing for Q3 2019, filed 15 Oct 2019.